Saskatoon's vaccine development cluster enhanced with new commercialization arm


A new consortium created to bring critical yet commercially promising vaccines to market is bolstering Saskatoon's growing reputation as a global powerhouse for human and animal vaccine development. Supported by the federal Centres of Excellence in Commercialization and Research (CECR) program, the Pan-Provincial Vaccine Enterprise (PREVENT) intends to draw on vaccine research strengths from at least three organizations

In-kind support of $10.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.